Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Latest News

Corporate venturing deal net: 29 June-3 July 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Velodyne visualises reverse merger
A year after reportedly hiring banks for an IPO, multi-corporate-backed Velodyne has instead chosen a reverse merger to list on the New York Stock Exchange.
Nasdaq receives Accolade in $220m IPO
Comcast, McKesson, Humana and Independence Health all scored exits as the health benefits services provider floated in an upscaled offering.
Caffeine rushes to $113m series D
The livestreaming broadcaster was valued at more than $600m in a round co-led by investors including Cox Enterprises and Fox Corporation.
CF PharmTech sees its way to $50m
Drug developer CF PharmTech has raised $50m in an SAIC-backed series F round just six months after closing $90m in series E funding.
VMware devours Datrium in acquisition deal
Samsung Catalyst Fund is exiting data recovery technology provider Datrium, which was valued at about $280m in its last funding round.
Evidation Health generates $45m results
McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m.

News Continued

Seeds Capital seeks corporates for $36m voyage
Innoport, PSA Unboxed and KSL Maritime Ventures are among the partners in a government-backed scheme to boost maritime technology in Singapore.
B2C2 becomes SBI partner in $30m deal
The crypto trading firm has received $30m in funding from SBI Financial Services as it aims to expand its offering into a prime brokerage.
Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Annexon adds $100m
The round pushed the overall funding for the Novartis-backed autoimmune and neurodegenerative disorder drug developer past $250m.
Google points North to acquisition
Google paid a reported $180m for Amazon and Intel-backed North Wearables, the augmented reality glasses developer having sought a buyer since spring.
B Capital captures $820m for second fund
The venture firm, which is partners with Boston Consulting Group, said it now has in excess of $1.4bn of assets under management.

Editor's Picks

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Amazon assembles $2bn Climate Pledge Fund
Areas to be targeted by Climate Pledge Fund will include transport, logistics, manufacturing, materials, renewable energy, food and agriculture technology.
Forma Therapeutics finishes IPO at $319m
Forma Therapeutics, whose investors include Eli Lilly and Novartis, has closed its IPO after seeing its shares double in price.
test reg

Login